Benzinga's Volume Movers

surged 26.76% to $10.26. The volume of Conatus Pharmaceuticals shares traded 7557% higher than normal. Conatus Pharmaceuticals announced plans to report top-line results of its clinical trials of Emricasan on January 8.

shares climbed 10.26% to $25.24. The volume of Cempra shares traded was 1348% higher than normal. On Sunday, Cempra announced positive results from its pneumonia study; meeting primary and secondary objectives.

shares rose 8.67% to $66.91. The volume of Isis Pharmaceuticals shares traded was 403% higher than normal. Isis Pharmaceuticals announced a deal with Johnson & Johnson's Janssen Biotech Inc.

shares moved up 5.07% to $40.44. The volume of Ingles Markets traded was 285% higher than normal. Ingles Markets shares have jumped 43.57% over the past 52 weeks, while the S&P 500 index has gained 12.67% in the same period.